drugset / Trial / NCT06884085
A Study to Compare to PK Characteristics and Safety Profiles Between AD-227 and Co-administration of AD-227A and AD-227B
RandomizedCrossoverOpen-labelTreatment
Summary
Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of AD-227 in healthy subjects.
Timeline
- Start
- 2025-07-12
- Primary completion
- 2025-08-13
- Completion
- 2025-08-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AD-227 | Unknown | — | Oral |
| Subject | AD-227A | Unknown | — | Oral |
| Subject | AD-227B | Unknown | — | Oral |